Symphony Limited Q1 FY27 Revenue at ₹378 Cr, EBITDA at ₹48 Cr; Declares Interim Dividend
Symphony Limited reported Q1 FY27 consolidated revenue of ₹378 crore (up 8% YoY) and EBITDA of ₹48 crore (up 26% YoY). Standalone revenue was ₹241 crore (up 5% YoY) with EBITDA at ₹30 crore (up 25% YoY). The company declared an interim dividend of ₹1 per share for FY26-27.
The results show positive growth and a dividend payout, which are generally positive for shareholders. However, the impact is moderated by some segments showing revenue decline and the presence of one-off expenses.
The company reported growth in revenue and EBITDA for both consolidated and standalone segments, along with an improved EBITDA margin. The declaration of an interim dividend also contributes positively.
Symphony Limited has announced its financial results for the first quarter of FY27, reporting its second-highest June quarter consolidated revenue and EBITDA. Consolidated revenue from operations stood at ₹378 crore, an 8% year-on-year increase, while EBITDA grew by 26% to ₹48 crore. The EBITDA margin improved by 1.9% to 12.6%.
On a standalone basis, revenue from operations was ₹241 crore, a 5% year-on-year growth, with EBITDA rising by 25% to ₹30 crore. The standalone EBITDA margin also saw an improvement of 2.0% to 12.3%.
The company's Board of Directors, in a meeting held on August 04, 2026, approved the first interim dividend of ₹1 per share for FY2026-27, with an approximate payout of ₹6.87 crore.
Mr. Nrupesh Shah, Managing Director (Corporate Affairs), Symphony Limited, commented that the performance reflects resilient domestic demand, disciplined execution, and progress on strategic diversification. The Beyond India Summer Products (BISP) division contributed ₹560 crore in trailing twelve-month revenue, representing 48% of consolidated performance, reinforcing diversification from the Indian summer. Bonaire USA recorded 35% revenue growth, and GSK China delivered 43% revenue growth. However, IMPCO Mexico revenue declined by 18% and CTPL Australia revenue softened by 11% due to a muted summer and disruptions, respectively.
Profitability was impacted by ₹5 crore of one-off non-cash expenses in Q1 FY27 and ₹9 crore higher other income in Q1 FY26. On the standalone front, India revenue grew 15%, supported by volume growth and strong performance in modern trade and digital channels. Exports declined due to lower subsidiary and third-party sales, compounded by geopolitical and shipping disruptions. Gross and EBITDA margins remained resilient despite cost increases.
What to do with a filing like this
Symphony Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Symphony Limited. Read the original for the full detail.